Derwent London said on Thursday that it has exchanged contracts with investment manager Titan Investors for the sale of its 70,300 sq ft freehold interest in Turnmill EC1 for £77.35m.
(Sharecast News) - Hollywood Bowl reported a record first-half revenue of £119.2m in a trading update on Tuesday, making for an 8.1% increase year-on-year.
Global investment manager Ninety One said in an update on Tuesday that its assets under management amounted to £126bn as of 31 March.
(Sharecast News) - Superdry is to delist from the London Stock Exchange as part of a far-reaching restructuring plan, the struggling retailer confirmed on Tuesday.
Discount retailer B&M reported growth in revenue across its fascias in a full-year update on Tuesday, with B&M UK achieving £4.41bn, marking a 4% increase.
GSK announced on Tuesday that its five-in-one meningococcal ABCWY (MenABCWY) vaccine candidate had been accepted for regulatory review by the US Food and Drug Administration (FDA).
Online marketplace operator Auction Technology Group reported a 6% improvement in first-half revenue in an update on Tuesday, to $86m, as it narrowed its full-year margin guidance.
Scientific technology specialist Oxford Instruments said in an update on Tuesday that trading in the financial year just ended was in line with expectations, with positive momentum in revenue growth.
(Sharecast News) - Global recruiter Hays reported a fall in net fees in a challenging third quarter on Tuesday, down 17% in total year-on-year, and 14% lower on a like-for-like basis.
(Sharecast News) - Global payments technology company Wise continued to enjoy a strong uptake for its services during the last quarter of its fiscal year.
(Sharecast News) - Plus500 reported a solid first-quarter performance in an update on Tuesday, with the company tracking ahead of market expectations for the 2024 financial year.
Great Portland Estates struck an upbeat note on Thursday, on the back of strong demand and a likely cut in interest rates.
RNAi medicines data and development specialist e-Therapeutics proposed a fundraise and its delisting from AIM on Wednesday.
